Gainers
- Sonoma Pharmaceuticals SNOA stock moved upwards by 26.4% to $3.26 during Tuesday's pre-market session. The company's market cap stands at $4.3 million.
- Aclaris Therapeutics ACRS shares increased by 19.1% to $3.74. The company's market cap stands at $267.1 million.
- Alumis ALMS shares rose 15.74% to $10.0. The market value of their outstanding shares is at $544.0 million. The company's, Q3 earnings came out 4 days ago.
- TFF Pharmaceuticals TFFP shares rose 15.41% to $0.42. The company's market cap stands at $1.4 million.
- HCW Biologics HCWB shares increased by 15.32% to $1.43. The company's market cap stands at $54.0 million. As per the press release, Q3 earnings came out 3 days ago.
- Fresh2 Group FRES stock rose 14.36% to $1.1. The company's market cap stands at $26.9 million.
Losers
- Apollomics APLM stock fell 16.3% to $0.16 during Tuesday's pre-market session. The market value of their outstanding shares is at $17.8 million.
- Incyte INCY stock fell 12.31% to $67.5. The market value of their outstanding shares is at $13.0 billion.
- Cytek Biosciences CTKB stock declined by 10.78% to $5.38. The market value of their outstanding shares is at $693.0 million.
- Grifols GRFS shares fell 10.42% to $8.26. The company's market cap stands at $5.6 billion.
- GlucoTrack GCTK shares decreased by 9.8% to $0.26. The company's market cap stands at $1.4 million. As per the press release, Q3 earnings came out 3 days ago.
- Alkermes ALKS stock decreased by 9.26% to $25.0. The company's market cap stands at $4.0 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ALKSAlkermes PLC
$31.515.15%
ALMSAlumis Inc
$8.822.20%
APLMApollomics Inc
$9.24-1.39%
CTKBCytek Biosciences Inc
$6.322.10%
FRESFresh2 Group Ltd
$1.269.57%
GCTKGlucoTrack Inc
$0.269821.7%
GRFSGrifols SA
$7.51-2.72%
HCWBHCW Biologics Inc
$0.44006.54%
INCYIncyte Corp
$68.822.62%
SNOASonoma Pharmaceuticals Inc
$2.49-2.35%
TFFPTFF Pharmaceuticals Inc
$0.1350107.7%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in